YY/T 0870.2-2013 Replaced

YY/T 0870.2-2013 Test for genotoxicity of medical devices—Part 2:In vitro mammalian chromosome aberration test

This part of YY/T 0870 specifies the method for testing chromosomal aberrations in vitro in mammalian cells of medical devices/materials.
〖HT5"H〗 Note: 〖HT5"SS〗 For the in vitro chromosomal aberration test of oral materials in mammalian cells, please refer to YY/T 0127.16.

Publish Date: 2013-10-21

YY/T 0870.3-2013 Replaced

YY/T 0870.3-2013 Test for genotoxicity of medical devices—Part 3:In vitro mammalian cell gene mutation test using mouse lymphoma cells

This part of YY/T 0870 specifies the method for conducting in vitro mammalian cell gene mutation tests on medical devices/materials using the mouse lymphoma cell line (L5178Y TK+/-3.7.2C).
The recommended test method in this part is the microwell plate method.

Publish Date: 2013-10-21

YY/T 0871-2013 Replaced

YY/T 0871-2013 Ophthalmic optics—Contact lenses—Hygienic management of multipatient use trial contact lenses

This standard provides guidance for contact lens manufacturers to write relevant information and provide it to eye care professionals for hygienic processing of soft and hard permeable (RGP) contact lenses worn by multiple patients.
For examples of label information, please refer to Appendix A.
This standard does not address the following issues:
——National norms for contact lens labels;
——Since there are no reported cases of prion virus transmission through contact lenses, there is no mention of prion virus inactivation.

Publish Date: 2013-10-21

YY/T 0893-2013 Replaced

YY/T 0893-2013 Gas mixers for medical use—Stand-alone gas mixers

This standard specifies the performance and safety requirements for medical standalone gas mixers intended to be connected to medical gas supply systems. The basic principles of some requirements are given in Appendix B.
This standard does not apply to:
a) Flowmeters with independent control of each gas flow rate;
b) Gas mixers that mix oxygen and ambient air;
c) Gas mixers that rely on other medical equipment to meet the functional requirements of this standard.

Publish Date: 2013-10-21

YY/T 0907-2013 Replaced

YY/T 0907-2013 Needle-free injectors for medical use—Requirements and test methods

This standard applies to the safety, performance, and testing requirements of needle-free injectors for single or multiple use by patients in clinical and related medical environments.
The dose chamber of the injector is usually disposable and is replaced after a single use or a limited number of uses. Sometimes, it is separate from the injection mechanism and is commonly referred to as a "cartridge", "ampoule", "syringe", "capsule", or "disc". Conversely, the dose chamber can also be a permanent inner chamber, the performance of which can remain effective within its expiration date.
This standard does not apply to the methods of drug administration:
——[ZK(]The penetration of a part of the needle-free injection device itself into or through the skin or mucous membrane (such as needles, tips, microneedles, implantable slow-release drug devices); [ZK)]
——[ZK(]The generation of aerosols, droplets, powders, or other forms for inhalation, insufflation, or nasal or oral deposition (such as sprays, inhalers, or micro-devices); [ZK)]
——[ZK(]The passive diffusion or ingestion by the human body of liquids, powders, or other substances deposited on the surface of the skin or mucous membrane (such as transdermal absorption patches, droplets); [ZK)]
——Applications of acoustic or electromagnetic energy (such as ultrasound or iontophoresis devices);
——[ZK(]Applications of infusion systems for accumulating or measuring drugs entering or passing through artificial tubes, catheters, and/or needles entering the human body themselves. [ZK)]

Publish Date: 2013-10-21

YY/T 0910.1-2013 Replaced

YY/T 0910.1-2013 Medical electrical equipment—Medical image display systems—Part 1:Evaluation methods

〖WTBZ〗This part of YY/T 0910 describes the test methods for medical 〖HT5H〗image display systems 〖HT5SS〗.
The scope of this part refers solely to test methods that can be judged visually or performed using ordinary test equipment. More advanced or more quantitative 〖HT5H〗image display system 〖HT5SS〗measurement methods that can be carried out with these devices are beyond the scope of this part.
This part applies to medical 〖HT5H〗image display systems 〖HT5SS〗that can display monochrome image information on color or grayscale 〖HT5H〗image display systems 〖HT5SS〗(such as 〖HT5H〗cathode ray tubes (CRTs) 〖HT5SS〗displays, 〖HT5H〗flat panel displays 〖HT5SS〗, 〖HT5H〗projection systems 〖HT5SS〗). This part applies to medical 〖HT5H〗image display systems used for diagnosis (medical image interpretation for making clinical diagnoses) or observation (observing medical images for medical purposes rather than providing medical image interpretations), which have special requirements for image quality. Head-mounted 〖HT5H〗image display systems 〖HT5SS〗and 〖HT5H〗image display systems used for determining positioning and operating these systems are not included in the scope of this part.
This part does not include requirements for defining acceptance tests and stability tests, or requirements for the frequency of stability tests.

Publish Date: 2013-10-21

YY/T 1014-2013 Replaced

YY/T 1014-2013 Dental explorers

This standard specifies the dimensions, performance requirements, and test methods for dental probes.

Publish Date: 2013-10-21

YY/T 1199-2013 Replaced

YY/T 1199-2013 Triglycerides assay kit(Oxidase method)

This standard specifies the determination principle, requirements, test methods, marking, labeling, and user's manual for triglyceride determination kits (enzyme method), as well as their packaging, transportation, and storage.
This standard is applicable to the quality control of triglyceride determination kits (enzyme method), which are used for the quantitative determination of triglyceride (TG) in human serum or plasma in vitro.

Publish Date: 2013-10-21

YY/T 1200-2013 Replaced

YY/T 1200-2013 Glucose assay kit(Enzymic method)

This standard specifies the determination principle, requirements, test methods, marking, labeling, and user manuals, packaging, transportation, and storage of glucose determination kits (enzyme method).
This standard applies to glucose determination kits using the hexokinase method and oxidase method, which are used in clinical testing to quantitatively analyze the glucose concentration in body fluids such as serum, plasma, urine, and cerebrospinal fluid.

Publish Date: 2013-10-21

YY/T 1204-2013 Replaced

YY/T 1204-2013 Total bile acids assay kit(Enzyme cycle method)

This standard specifies the determination principle, requirements, test methods, marking, labels, and user manuals, packaging, transportation, and storage of total bile acid determination kits (enzyme cycling method).
This standard applies to the quality control of total bile acid determination kits (enzyme cycling method), which are used for the quantitative determination of total bile acid in human serum or plasma in vitro.

Publish Date: 2013-10-21

YY/T 1213-2013 Replaced

YY/T 1213-2013 Follicle stimulating hormone quantitative labelling immunoassay kit

This standard specifies the classification, requirements, test methods, marking, labeling, user's manual, packaging, transportation, and storage of quantitative labeled immunoassay kits for follicle-stimulating hormone (FSH).
This standard applies to kits that quantitatively measure FSH based on the principle of a double antibody sandwich assay (hereinafter referred to as FSH kits). These include immunoassay kits that use enzyme-labeled, (electro) chemiluminescence-labeled, or (time-resolved) fluorescence-labeled methods for capture antibodies, and use microplates, tubes, magnetic particles, microbeads, and plastic beads as carriers for antibody coating to quantitatively measure FSH.
This standard does not apply to:
a) Colloidal gold-labeled FSH test strips;
b) Various FSH radioimmunoassay or immunoradiometry kits labeled with radioactive isotopes such as 125I.

Publish Date: 2013-10-21

YY/T 1214-2013 Replaced

YY/T 1214-2013 Human chorionic gonadotrophin quantitative labelling immunoassay kit

This standard specifies the classification, requirements, test methods, marking, labels and user manuals, packaging, transportation, and storage of quantitative labeled immunoassay kits for human chorionic gonadotropin (HCG).
This standard applies to kits that quantitatively measure HCG using the principle of a double antibody sandwich assay (hereinafter referred to as HCG kits). These include immunoassay kits that use enzyme-labeled, (electro) chemiluminescence-labeled, or (time-resolved) fluorescence-labeled methods for capture antibodies, and use microplates, tubes, magnetic particles, microbeads, and plastic beads as carriers for antibody coating to quantitatively measure HCG.
This standard does not apply to:
a) Colloidal gold-labeled HCG test strips;
b) Various HCG radioimmunoassay or immunoradiometric kits labeled with radioactive isotopes such as 125I.

Publish Date: 2013-10-21